Sarah Condella - 30 Apr 2021 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
SVP, Human Resources
Signature
/s/ Sarah Condella by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
30 Apr 2021
Net transactions value
-$632,765
Form type
4
Filing time
11 Jun 2021, 19:11:29 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $21,235 +328 +0.44% $64.74 74,380 30 Apr 2021 Direct F1
transaction EXAS Common Stock Sale $420,000 -3,500 -4.7% $120.00 70,880 10 Jun 2021 Direct F2
transaction EXAS Common Stock Options Exercise $9,808 +1,950 +2.8% $5.03* 72,830 10 Jun 2021 Direct
transaction EXAS Common Stock Sale $234,000 -1,950 -2.7% $120.00 70,880 10 Jun 2021 Direct
holding EXAS Common Stock 4,922 30 Apr 2021 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Option (right to buy) Options Exercise $9,808 -1,950 -15% $5.03* 10,900 10 Jun 2021 Common Stock 1,950 $5.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased through Employee Stock Purchase Plan.
F2 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan.
F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.